ANDA 203807, held by Dr Reddys Labs SA. Clozapine.
As of Nov 15, 2026, ANDA 203807 (Clozapine), held by Dr Reddys Labs SA, was first approved by FDA on Sep 17, 2015, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 17, 2015 | Original application | Approved |
| Jun 13, 2025 | Supplement 17REMS | Approved | None posted |
| Nov 10, 2021 | Supplement 14REMS | Approved | None posted |
| Jul 29, 2021 | Supplement 13REMS | Approved | None posted |
| Feb 18, 2021 | Supplement 10REMS | Approved | None posted |
| Jan 16, 2019 | Supplement 6REMS | Approved | None posted |
| May 10, 2017 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 10, 2017 | Supplement 2Labeling · Standard review | Approved | None posted |
| May 10, 2017 | Supplement 3Labeling · Standard review | Approved | None posted |
| May 10, 2017 | Supplement 5Labeling · Standard review | Approved | None posted |
| Sep 17, 2015 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters